Study #2023-1016
Phase I study of HC-7366 in relapsed/refractory acute myeloid leukemia
MD Anderson Study Status
Enrolling
Treatment Agent
HC-7366
Description
To find a recommended dose of HC-7366 to patients with AML. The safety and effects of this drug combination will also be studied.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Acute Myeloid Leukemia
Study phase:
Phase I
Physician name:
Abhishek Maiti
Department:
Leukemia
For general questions about clinical trials:
1-844-955-5036
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.